Herantis taps Indivi for digital biomarker tech in Parkinson’s disease trial

Finnish biotech Herantis Pharma is teaming up with Swiss medtech Indivi to help seek early detection of Parkinson’s disease (PD) in a new proof-of-concept clinical trial. Finnish biotech Herantis Pharma is teaming up with Swiss medtech Indivi to help seek early detection of Parkinson’s disease in a new proof-of-concept clinical trial. Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Trending Biologics Clinical Development Ophthalmology Cell & Gene Therapy Drug Development Small Molecule Research & Development Fierce 50 Special Report Awards Gala Awards Outsourcing Awards Innovation Awards…

Source: FierceBiotech